No COVID-19 testing at home yet but quicker options coming
Home testing for the new coronavirus may sound like a good idea, but U.S. regulators say it's still too risky.
Apr 5, 2020
0
209
Home testing for the new coronavirus may sound like a good idea, but U.S. regulators say it's still too risky.
Apr 5, 2020
0
209
The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.
Nov 25, 2013
0
0
(HealthDay)—The flu seems to be easing its grip on the United States, federal health officials reported Friday.
Feb 9, 2013
0
0
(AP) -- A vaccine against cervical cancer hasn't been all that popular for girls. It may be even a harder sell for boys now that it's been recommended for them too.
Oct 25, 2011
5
0
Four years ago, as attention locked onto COVID-19, another virus began circling the globe. A major outbreak of a new strain of bird flu—formally named influenza A virus subtype H5N1—has since killed millions of wild birds ...
Jul 2, 2024
0
3
A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots.
Jun 6, 2024
0
13
Farmworkers face some of the most intense exposures to the bird flu virus, but advocates say many of them would lack resources to fall back on if they became ill.
Jun 3, 2024
0
0
The animal tranquilizer xylazine's spread into Philadelphia's illicit opioid supply has introduced new hazards to an already dangerous drug crisis, sending people in addiction into intense blackouts and leaving them with ...
May 20, 2024
0
0
As COVID-19 swept over Phoebe Putney Health System and Southwest Georgia in the first days of the pandemic, residents and public health officials were desperate to know what patients had and how far it was spreading. The ...
May 9, 2024
0
0
Patients with COVID-19 had lower viral loads if treated with metformin, according to new University of Minnesota research that argues for broader use of the cheap anti-diabetes drug and against the controversial use of ivermectin.
May 4, 2024
2
2